• [1]
    Edmond, M.B., Wallace, S.E., McClish, D.K., Pfaller, M.A., Jones, R.N., Wenzel, R.P. (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29, 239244.
  • [2]
    Lewis, R.E., Lo, H.J., Raad, I.I., Kontoyiannis, D.P. (2002) Lack of catheter infection by the efg1/efg1 cph1/cph1 double-null mutant, a Candida albicans strain that is defective in filamentous growth. Antimicrob. Agents Chemother. 46, 11531155.
  • [3]
    Morschhäuser, J. (2002) The genetic basis of fluconazole resistance development in Candida albicans. Biochim. Biophys. Acta 1587, 240248.
  • [4]
    Sanglard, D., Odds, F.C. (2002) Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2, 7385.
  • [5]
    Cutfield, S.M., Dodson, E.J., Anderson, B.F., Moody, P.C., Marshall, C.J., Sullivan, P.A., Cutfield, J.F. (1995) The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. Structure 3, 12611271.
  • [6]
    Calderone, R.A., Fonzi, W.A. (2001) Virulence factors of Candida albicans. Trends Microbiol. 9, 327335.
  • [7]
    Hoyer, L.L. (2001) The ALS gene family of Candida albicans. Trends Microbiol. 9, 176180.
  • [8]
    Nantel, A., Dignard, D., Bachewich, C., Harcus, D., Marcil, A., Bouin, A.P., Sensen, C.W., Hogues, H., van het Hoog, M., Gordon, P., Rigby, T., Benoit, F., Tessier, D.C., Thomas, D.Y., Whiteway, M. (2002) Transcription profiling of Candida albicans cells undergoing the yeast-to-hyphal transition. Mol. Biol. Cell 13, 34523465.
  • [9]
    Hube, B., Naglik, J. (2001) Candida albicans proteinases: resolving the mystery of a gene family. Microbiology 147, 19972005.
  • [10]
    Naglik, J.R., Newport, G., White, T.C., Fernandes-Naglik, L.L., Greenspan, J.S., Greenspan, D., Sweet, S.P., Challacombe, S.J., Agabian, N. (1999) In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect. Immun. 67, 24822490.
  • [11]
    Staib, P., Kretschmar, M., Nichterlein, T., Hof, H., Morschhäuser, J. (2002) Host versus in vitro signals and intrastrain allelic differences in the expression of a Candida albicans virulence gene. Mol. Microbiol. 44, 13511366.
  • [12]
    Hube, B., Stehr, F., Bossenz, M., Mazur, A., Kretschmar, M., Schäfer, W. (2000) Secreted lipases of Candida albicans: cloning, characterisation and expression analysis of a new gene family with at least ten members. Arch. Microbiol. 174, 362374.
  • [13]
    Jaeger, K.E. (1994) Extracellular enzymes of Pseudomonas aeruginosa as virulence factors. Immun. Infekt. 22, 177180.
  • [14]
    Gillum, A.M., Tsay, E.Y.H., Kirsch, D.R. (1984) Isolation of the Candida albicans gene for orotidine-5-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198, 179182.
  • [15]
    Kretschmar, M., Hube, B., Bertsch, T., Sanglard, D., Merker, R., Schröder, M., Hof, H., Nichterlein, T. (1999) Germ tubes and proteinase activity contribute to virulence of Candida albicans in murine peritonitis. Infect. Immun. 67, 66376642.
  • [16]
    Schaller, M., Schäfer, W., Korting, H.C., Hube, B. (1998) Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity. Mol. Microbiol. 29, 605615.
  • [17]
    Donnelly, S.M., Sullivan, D.J., Shanley, D.B., Coleman, D.C. (1999) Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 145, 18711882.
  • [18]
    Sambrook, J., Fritsch, E.R. and Maniatis, T. (1998) Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  • [19]
    Maneu, V., Cervera, A.M., Martinez, J.P., Gozalbo, D. (1996) Molecular cloning and characterization of a Candida albicans gene (EFB1) coding for the elongation factor EF-1β. FEMS Microbiol. Lett. 145, 157162.
  • [20]
    Felk, A., Kretschmar, M., Albrecht, A., Schaller, M., Beinhauer, S., Nichterlein, T., Sanglard, D., Korting, H.C., Schäfer, W., Hube, B. (2002) Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infect. Immun. 70, 36893700.
  • [21]
    Staib, P., Kretschmar, M., Nichterlein, T., Hof, H., Morschhäuser, J. (2000) Differential activation of a Candida albicans virulence gene family during infection. Proc. Natl. Acad. Sci. USA 97, 61026107.
  • [22]
    McCourtie, J., Douglas, L.J. (1984) Relationship between cell surface composition, adherence, and virulence of Candida albicans. Infect. Immun. 45, 612.
  • [23]
    Göttlich, E., de Hoog, G.S., Yoshida, S., Takeo, K., Nishimura, K., Miyaji, M. (1995) Cell-surface hydrophobicity and lipolysis as essential factors in human tinea nigra. Mycoses 38, 489494.
  • [24]
    Schaller, M., Korting, H.C., Schäfer, W., Bastert, J., Chen, W., Hube, B. (1999) Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Mol. Microbiol. 34, 169180.
  • [25]
    Lan, C.Y., Newport, G., Murillo, L.A., Jones, T., Scherer, S., Davis, R.W., Agabian, N. (2002) Metabolic specialization associated with phenotypic switching in Candida albicans. Proc. Natl. Acad. Sci. USA 99, 1490714912.
  • [26]
    Kvaal, C., Lachke, S.A., Srikantha, T., Daniels, K., McCoy, J., Soll, D.R. (1999) Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect. Immun. 67, 66526662.
  • [27]
    Bowden, M.G., Visai, L., Longshaw, C.M., Holland, K.T., Speziale, P., Hook, M. (2002) Is the GehD lipase from Staphylococcus epidermidis a collagen-binding adhesin. J. Biol. Chem. 277, 4301743023.
  • [28]
    Banno, Y., Yamada, T., Nozawa, Y. (1985) Secreted phospholipases of the dimorphic fungus, Candida albicans; separation of three enzymes and some biological properties. Sabouraudia 23, 4754.
  • [29]
    Ibrahim, A.S., Mirbod, F., Filler, S.G., Banno, Y., Cole, G.T., Kitajima, Y., J.E. Edwards, Jr., Nozawa, Y., Ghannoum, M.A. (1995) Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect. Immun. 63, 19931998.
  • [30]
    König, B., Jaeger, K.E., Sage, A.E., Vasil, M.L., König, W. (1996) Role of Pseudomonas aeruginosa lipase in inflammatory mediator release from human inflammatory effector cells (platelets, granulocytes, and monocytes). Infect. Immun. 64, 32523258.
  • [31]
    Rollof, J., Braconier, J.H., Soderstrom, C., Nilsson-Ehle, P. (1998) Interference of Staphylococcus aureus lipase with human granulocyte function. Eur. J. Clin. Microbiol. Infect. Dis. 7, 505510.
  • [32]
    Long, J.P., Hart, J., Albers, W., Kapral, F.A. (1992) The production of fatty acid modifying enzyme (FAME) and lipase by various staphylococcal species. J. Med. Microbiol. 37, 232234.